Table 3.
Description of individuals with BD on mood-stabilizer medication.
| Bipolar with mood stabilizer | Whole | Lipophilic | Hydrophilic | Other | ||||
|---|---|---|---|---|---|---|---|---|
| N=286268 | SD or % | N=18267 | SD or % | N=7307 | SD or % | N=260694 | SD or % | |
| Mean age SD | 55.41 | 11.34 | 56.8 | 10.3 | 56.87 | 10.13 | 55.28 | 11.43 |
| Male | 238625 | 83.36% | 15976 | 87.46% | 6302 | 86.25% | 216347 | 82.99% |
| Race | ||||||||
| White | 233821 | 81.68% | 15221 | 83.33% | 6104 | 83.54% | 212496 | 81.51% |
| Non-White | 41238 | 14.41% | 2308 | 12.63% | 898 | 12.29% | 38032 | 14.59% |
| Missing | 11209 | 3.92% | 738 | 4.04% | 305 | 4.17% | 10166 | 3.9% |
| Ever married | 246998 | 86.28% | 15971 | 87.43% | 6502 | 88.98% | 224525 | 86.13% |
| with service percentage >=50% | 126007 | 44.02% | 7867 | 43.07% | 2990 | 40.92% | 115150 | 44.17% |
| Fiscal year | ||||||||
| FY11 | 32946 | 11.51% | 1454 | 7.96% | 1418 | 19.41% | 30074 | 11.54% |
| FY12 | 71876 | 25.11% | 2478 | 13.57% | 3346 | 45.79% | 66052 | 25.34% |
| FY13 | 73489 | 25.67% | 6626 | 36.27% | 1269 | 17.37% | 65594 | 25.16% |
| FY14 | 73066 | 25.52% | 5457 | 29.87% | 896 | 12.26% | 66713 | 25.59% |
| FY15 | 34891 | 12.19% | 2252 | 12.33% | 378 | 5.17% | 32261 | 12.38% |
| Psychiatric condition | ||||||||
| major depression | 109158 | 38.13% | 6404 | 35.06% | 2503 | 34.25% | 100251 | 38.46% |
| PTSD | 100897 | 35.25% | 5878 | 32.18% | 2314 | 31.67% | 92705 | 35.56% |
| Alcohol use disorder | 69117 | 24.14% | 3678 | 20.13% | 1366 | 18.69% | 64073 | 24.58% |
| Other substance use disorder | 59663 | 20.84% | 2964 | 16.23% | 1072 | 14.67% | 55627 | 21.34% |
| Psychiatric medication use | ||||||||
| Prescribed ATP | 137213 | 47.93% | 8426 | 46.13% | 3435 | 47.01% | 125352 | 48.08% |
| Antipsychotics coverage >=80% | 60215 | 21.03% | 3909 | 21.4% | 1600 | 21.9% | 54706 | 20.98% |
| Prescribed clozapine | 277 | 0.1% | 13 | 0.07% | 4 | 0.05% | 260 | 0.1% |
| Prescribed mood stabilizer medication | 286268 | 100% | 18267 | 100% | 7307 | 100% | 260694 | 100% |
| Mood stabilizer medication coverage >=80% | 129612 | 45.28% | 8582 | 46.98% | 3489 | 47.75% | 117541 | 45.09% |
| Prescribed antidepressant | 211314 | 73.82% | 13191 | 72.21% | 5299 | 72.52% | 192824 | 73.97% |
| Prescribed anti-anxiety medication | 142628 | 49.82% | 8294 | 45.4% | 3471 | 47.5% | 130863 | 50.2% |
| Prescribed substance use disorder medication | 26805 | 9.36% | 1309 | 7.17% | 519 | 7.1% | 24977 | 9.58% |
| Service use | ||||||||
| Hospitalized for somatic reason | 49987 | 17.46% | 2470 | 13.52% | 907 | 12.41% | 46610 | 17.88% |
| Emergency room use | 101884 | 35.59% | 5441 | 29.79% | 2050 | 28.06% | 94393 | 36.21% |
| PRRC visits | 7.7 | 0.71 | 7.45 | 0.68 | 7.27 | 0.61 | 7.73 | 0.71 |
| MHICM visits | 5.17 | 0.64 | 4.61 | 0.54 | 4.58 | 0.55 | 5.22 | 0.65 |
| Other mental health outpatient visits | 13.71 | 7.96 | 12.2 | 6.83 | 11.36 | 6.38 | 13.87 | 8.08 |
| Substance use visits | 10.65 | 2.16 | 9.67 | 1.65 | 8.92 | 1.4 | 10.76 | 2.22 |
| Somatic outpatient visits | 18.45 | 19.88 | 16.63 | 17.21 | 16.95 | 17.85 | 18.59 | 20.12 |
| Somatic outpatient visits during 3M post | 12.2 | 12.64 | 10.61 | 10.52 | 10.42 | 10.51 | 12.33 | 12.85 |
| Carlson Comorbidity Index | ||||||||
| 0 | 125230 | 43.75% | 7964 | 43.6% | 3035 | 41.54% | 114231 | 43.82% |
| 1 | 90077 | 31.47% | 5947 | 32.56% | 2461 | 33.68% | 81669 | 31.33% |
| 2+ | 70961 | 24.79% | 4356 | 23.85% | 1811 | 24.78% | 64794 | 24.85% |
FY: Fiscal year in which incident medication episode began; PTSD: Post- Traumatic Stress Disorder; ATP: Prescribed Anti-Psychotic; PPRC: Count of Psychosocial Rehabilitation and Recovery Center visits; MHICM: Count of Mental Health Intensive Case Management visits.